CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 84 filers reported holding CTI BIOPHARMA CORP in Q2 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $83,000 | -8.8% | 28,400 | 0.0% | 0.00% | – |
| Q4 2020 | $91,000 | +49.2% | 28,400 | 0.0% | 0.00% | – |
| Q3 2020 | $61,000 | +84.8% | 28,400 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | +26.9% | 28,400 | 0.0% | 0.00% | – |
| Q1 2020 | $26,000 | -42.2% | 28,400 | 0.0% | 0.00% | – |
| Q4 2019 | $45,000 | +87.5% | 28,400 | 0.0% | 0.00% | – |
| Q3 2019 | $24,000 | 0.0% | 28,400 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | -14.3% | 28,400 | 0.0% | 0.00% | – |
| Q1 2019 | $28,000 | +33.3% | 28,400 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -65.6% | 28,400 | 0.0% | 0.00% | – |
| Q3 2018 | $61,000 | -56.7% | 28,400 | 0.0% | 0.00% | – |
| Q2 2018 | $141,000 | +27.0% | 28,400 | 0.0% | 0.00% | – |
| Q1 2018 | $111,000 | +46.1% | 28,400 | 0.0% | 0.00% | – |
| Q4 2017 | $76,000 | -16.5% | 28,400 | 0.0% | 0.00% | – |
| Q3 2017 | $91,000 | -3.2% | 28,400 | 0.0% | 0.00% | – |
| Q2 2017 | $94,000 | -21.0% | 28,400 | 0.0% | 0.00% | – |
| Q1 2017 | $119,000 | – | 28,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|